is retatrutide a glp 1 agonist vs Semaglutide and Tirzepatide: GLP-3 Facts explained Retatrutide vs Tirzepatide: Which Weight-Loss

The trials of both Ma et al

Evidence supports the potential benefits of GLP-1RAs in IBD management, yet current data do not rule out metabolic factors as contributing to these benefits

Patients need to understand what each component does, why it was prescribed, and how to manage the different side effect profiles

These compound-specific effects could affect the way in which individual DPP4i are used therapeutically and potentially explain off-target adverse effects, such as hospitalization for heart failure, which is seen only with one DPP4i

Why dual agonism outperforms single-receptor activation Single GLP-1 agonists like semaglutide produce substantial weight loss, typically 10-15% body weight reduction over 6-12 months